Clinical and serological findings of giant-cell arteritis

被引:0
作者
Vaith, P. [1 ]
Warnatz, K. [1 ]
机构
[1] Univ Freiburg Klinikum, Med Klin, Abt Rheumatol & Klin Immunol, D-79106 Freiburg, Germany
来源
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2009年 / 68卷 / 02期
关键词
Giant cell arteritis; Polymyalgia rheumatica; Vasculitis; C-reactive protein; C-REACTIVE PROTEIN; ERYTHROCYTE SEDIMENTATION-RATE; POSITRON-EMISSION-TOMOGRAPHY; COMPLICATION AORTIC-ANEURYSM; POLYMYALGIA-RHEUMATICA; TEMPORAL ARTERITIS; CLASSIFICATION; INVOLVEMENT; PREVALENCE; DISSECTION;
D O I
10.1007/s00393-008-0377-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Giant cell arteritis (GCA) frequently appears as cranial arteritis (eg. temporal arteritis) with headache, pain on chewing and visual disturbances. In addition, extracranial manifestations are often observed leading to aneurysmatic dilatations and dissections of the aorta as well as stenoses of large thoracic, abdominal or limb arteries. The vascular signs are accompanied by general disease symptoms, e. g. malaise, elevated temperatures, weight loss and depression. Polymyalgia rheumatica (PMR) is the most frequent rheumatic manifestation of GCA but also occurs independently from GCA. The structural correlate for the PMR symptoms is first and foremost extra-articular inflammation (tenosynovitis, bursitis) of large joints and the vertebral column (interspinal bursitis). In addition, vasculitis of large arteries in PMR must be considered particularly in the presence of high inflammatory activity. While specific laboratory markers for GCA and PMR are lacking elevated values for the erythrocyte sedimentation rate and C-reactive protein are present in almost all patients at disease onset. Besides the clinical evaluation, the serological acute phase reaction represents the main parameter for the course during therapy of this relatively frequent disease in elderly people.
引用
收藏
页码:124 / +
页数:7
相关论文
共 50 条
  • [1] Internistische und serologische Befunde der RiesenzellarteriitisClinical and serological findings of giant-cell arteritis
    P. Vaith
    K. Warnatz
    Zeitschrift für Rheumatologie, 2009, 68 (2)
  • [2] CONTROVERSIES REGARDING GIANT-CELL (TEMPORAL, CRANIAL) ARTERITIS
    ESHAGHIAN, J
    DOCUMENTA OPHTHALMOLOGICA, 1979, 47 (01) : 43 - 67
  • [3] CLINICAL AND LABORATORY FINDINGS WITH GIANT-CELL ARTERITIS
    BERLIT, P
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1992, 111 (01) : 1 - 12
  • [4] Duplex Sonography in Giant-cell Arteritis
    Loeffler, Christian
    Hellmich, Bernhard
    AKTUELLE RHEUMATOLOGIE, 2019, 44 (04) : 253 - 261
  • [5] THE ETIOPATHOGENESIS OF GIANT-CELL ARTERITIS
    STEVENS, RJ
    HUGHES, RA
    BRITISH JOURNAL OF RHEUMATOLOGY, 1995, 34 (10): : 960 - 965
  • [6] Giant cell arteritis: Update on clinical manifestations, diagnosis, and management
    Farina, Nicola
    Tomelleri, Alessandro
    Campochiaro, Corrado
    Dagna, Lorenzo
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 107 : 17 - 26
  • [7] Recent Advances in Diagnostic Strategies for Giant Cell Arteritis
    Kermani, Tanaz A.
    Warrington, Kenneth J.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2012, 12 (02) : 138 - 144
  • [8] THE CLINICAL SPECTRUM OF GIANT-CELL ARTERITIS
    MERTENS, JCC
    VANDISSEL, JT
    KIBBELAAR, RE
    BREEDVELD, FC
    NETHERLANDS JOURNAL OF MEDICINE, 1993, 42 (3-4) : 99 - 104
  • [9] Giant cell arteritis
    Pepper, Kristie
    POSTGRADUATE MEDICINE, 2023, 135 : 22 - 32
  • [10] Giant-cell arteritis pathogenesis
    Samson, Maxime
    Bonnotte, Bernard
    PRESSE MEDICALE, 2012, 41 (10): : 937 - 947